Briganti Stefania, Flori Enrica, Bellei Barbara, Picardo Mauro
Laboratory of Cutaneous Physiopathology, San Gallicano Dermatologic Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
PLoS One. 2014 Aug 7;9(8):e104045. doi: 10.1371/journal.pone.0104045. eCollection 2014.
Peroxisome proliferator-activated receptor gamma (PPARγ) may be involved in a key mechanism of the skin aging process, influencing several aspects related to the age-related degeneration of skin cells, including antioxidant unbalance. Therefore, we investigated whether the up-modulation of this nuclear receptor exerts a protective effect in a stress-induced premature senescence (SIPS) model based on a single exposure of human dermal fibroblasts to 8-methoxypsoralen plus + ultraviolet-A-irradiation (PUVA). Among possible PPARγ modulators, we selected 2,4,6-octatrienoic acid (Octa), a member of the parrodiene family, previously reported to promote melanogenesis and antioxidant defense in normal human melanocytes through a mechanism involving PPARγ activation. Exposure to PUVA induced an early and significant decrease in PPARγ expression and activity. PPARγ up-modulation counteracted the antioxidant imbalance induced by PUVA and reduced the expression of stress response genes with a synergistic increase of different components of the cell antioxidant network, such as catalase and reduced glutathione. PUVA-treated fibroblasts grown in the presence of Octa are partially but significantly rescued from the features of the cellular senescence-like phenotype, such as cytoplasmic enlargement, the expression of senescence-associated-β-galactosidase, matrix-metalloproteinase-1, and cell cycle proteins. Moreover, the alterations in the cell membrane lipids, such as the decrease in the polyunsaturated fatty acid content of phospholipids and the increase in cholesterol levels, which are typical features of cell aging, were prevented. Our data suggest that PPARγ is one of the targets of PUVA-SIPS and that its pharmacological up-modulation may represent a novel therapeutic approach for the photooxidative skin damage.
过氧化物酶体增殖物激活受体γ(PPARγ)可能参与皮肤衰老过程的关键机制,影响与皮肤细胞衰老相关退化的多个方面,包括抗氧化失衡。因此,我们研究了在基于人皮肤成纤维细胞单次暴露于8-甲氧基补骨脂素加紫外线A照射(PUVA)的应激诱导早衰(SIPS)模型中,该核受体的上调是否发挥保护作用。在可能的PPARγ调节剂中,我们选择了2,4,6-辛三烯酸(Octa),它是聚二烯家族的成员,先前报道其通过涉及PPARγ激活的机制促进正常人黑素细胞中的黑色素生成和抗氧化防御。暴露于PUVA会导致PPARγ表达和活性早期显著下降。PPARγ上调可抵消PUVA诱导的抗氧化失衡,并降低应激反应基因的表达,同时协同增加细胞抗氧化网络的不同成分,如过氧化氢酶和还原型谷胱甘肽的表达。在Octa存在下生长的经PUVA处理的成纤维细胞部分但显著地从细胞衰老样表型的特征中得到挽救,如细胞质扩大、衰老相关β-半乳糖苷酶、基质金属蛋白酶-1和细胞周期蛋白的表达。此外,细胞膜脂质的改变,如磷脂中多不饱和脂肪酸含量的降低和胆固醇水平的升高,这些细胞衰老的典型特征也得到了预防。我们的数据表明,PPARγ是PUVA-SIPS的靶点之一,其药理学上调可能代表一种治疗光氧化皮肤损伤的新方法。